Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

250 ML sipuleucel-T 200000 CELLS/ML Injection [Provenge]

Known as: Provenge (minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF per 250 ML of Lactated Ringer's) Injection, PROVENGE 50,000,000 CELLS in 250 ML Injection, Provenge 50,000,000 CELLS per 250 ML Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Therapeutic cancer vaccines are an immunotherapy that targets tumor antigens to induce an active immune response. To date… Expand
2011
2011
Along with progresses in understanding the complex interactions between tumor cells and the immune response of the host and the… Expand
2005
2005
There are few therapeutic options available for the treatment of hormone-refractory prostate cancer (HRPC), but recent… Expand